Investigation of Flare and Remission in Subjects With Atopic Dermatitis

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 14, 2019

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Atopic Dermatitis
Interventions
DRUG

Cyclosporine A

"Initial treatment: Oral cyclosporine A (CsA) treatment (4-5 mg/kg/day) for 3 weeks.~Responders shift to oral low-dose CsA treatment (2-2.5 mg/kg/day) until onset of a second flare or until Week 16 (Day 113).~In case of a second AD flare, the subjects shift back to oral high-dose CsA treatment (4-5 mg/kg/day) for 3 weeks."

Trial Locations (1)

3015 GD

Investigational site, Rotterdam

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LEO Pharma

INDUSTRY